OpenBilldrug price receipt

NADAC week of 2026-10-14

FIORICET 50-300-40 MG CAPSULE

FDA nonproprietary name: butalbital, acetaminophen, and caffeine

For 30 capsules

Pharmacies pay

$264.71 filed

30 × $8.82367 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$210.77 filed

30 × $7.02553 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.80× estimated

Medicare paid 20% less than pharmacies pay.

Part D averages every strength and form sold under “Fioricet” / “Butalb/Acetaminophen/Caffeine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$309.42 estimated

$264.71 + $39.71 (15%) + $5.00 fee per fill = $309.42

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FIORICET 50-300-40 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as butalbital, acetaminophen, and caffeine, under the trade name “Fioricet”.

FDA gives its dosage form as capsule and its route as oral.

The labeler, the company named on the label, is Actavis Pharma, Inc.

FDA lists it under 3 Established Pharmacologic Classes: Barbiturate, Central Nervous System Stimulant and Methylxanthine.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 52544-0080-01.

NADAC classes it in its brand rate-setting class B-ANDA, and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $264.71 for 30 capsules (30 × $8.82367 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-01-01. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-01-01. The file is new; the price is not.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.31632 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name butalbital, acetaminophen, and caffeine with FIORICET 50-300-40 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
generic · capsule
$0.31632 per EA filed
eff. 2026-09-23
We don’t know yet
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
generic · tablet
$0.12231 per EA filed
eff. 2026-09-23
We don’t know yet
FIORICET 50-300-40 MG CAPSULE this page
brand · capsule
$8.82367 per EA filed
eff. 2026-01-01
$7.02553 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $8.82367 per EA filed.

Of the 10 other products in FDA’s Barbiturate class priced per EA, 0 have a higher middle NADAC price and 10 a lower one. The one in the middle is BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, at $0.87462 per EA filed (eff. 2026-09-23).

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 72 have a higher middle NADAC price and 131 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Of the 32 other products in FDA’s Methylxanthine class priced per EA, 1 has a higher middle NADAC price and 31 a lower one. The one in the middle is QC STAY AWAKE 200 MG TABLET, at $0.08299 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $210.77 for 30 capsules, at an average of $7.02553 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fioricet” and “Butalb/Acetaminophen/Caffeine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,556 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FIORICET 50-300-40 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fioricet / Butalb/Acetaminophen/Caffeine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.